[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350928-105":59,"doc-detail-350928-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breast-cancer-risk-level-and-prediction-of-tumor-aggressiveness-in-the-athena-breast-health-network","Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network","","Association between Breast Cancer Surveillance Consortium (BCSC) v2 risk scores and invasive breast cancer aggressiveness was evaluated in a prospective screening cohort. BCSC 5-year risk was estimated for 11,915 participants with median follow-up of 6.9 years, categorizing top 25% as high-risk and bottom 75% as low-risk. Outcomes included AJCC prognostic pathologic stage from registries. High BCSC risk related to non-advanced but not advanced invasive cancer, supporting endocrine risk reduction targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-risk-level-and-prediction-of-tumor-aggressiveness-in-the-athena-breast-health-network/350928/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-risk-level-and-prediction-of-tumor-aggressiveness-in-the-athena-breast-health-network/350928.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of this study?","Question",{"text":112,"@type":113},"To determine whether the BCSC v2 breast cancer risk score is associated with advanced and non-advanced invasive breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants categorized by risk level?",{"text":117,"@type":113},"Participants were classified as high-risk if they were in the top 25% and low-risk if they were in the bottom 75% based on age-specific BCSC risk standard.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about advanced versus non-advanced cancer?",{"text":121,"@type":113},"High BCSC risk among women diagnosed with breast cancer was associated with non-advanced invasive cancer, but it was not significantly associated with advanced invasive cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350928,1790154477,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Breast Cancer Research and Treatment (2026) 215:65 [https://doi.org/10.1007/s10549-025-07894-1](https://doi.org/10.1007/s10549-025-07894-1)  \nBreast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network  \nKatherine Leggat‑Barr1 · Tomiyuri Lewis1 · Jeffrey A. Tice1 · EleneTsopurashvili1 · Rosalyn Sayaman1 · Paige Warner1 · Kathy Malvin1 · Leah Sabacan1 · Alexandra Perry‑Solomon1 · Sarah Theiner1,2 · Irene Acerbi1 · Ann Griffin1 · Joseph McGuire1 · Vivian Lee1 · Alexander D. Borowsky3 · Wisdom Study and Athena Breast Health Network Investigators and Advocate Partners1 · Martin Eklund4 · Celia Kaplan1 · Robert A. Hiatt1 · Allison Stover Fiscalini1 · Karla Kerlikowske1 · Yiwey Shieh5 · Laura Esserman1 · Laura van’t Veer1,6  \nReceived: 8 October 2025 / Accepted: 30 December 2025 / Published online: 28 January 2026 © The Author(s) 2026  \nAbstract  \nPurpose Determine the association between the Breast Cancer Surveillance Consortium v2 model (BCSC) risk score and advanced and non-advanced invasive breast cancer (IBC) .  \nMethods We estimated BCSC 5-year invasive breast cancer risk for 11,915 participants in a prospective screening cohort with median follow-up of 6.9 years prior to breast cancer diagnosis. Individuals in the top 25% by age of BCSC risk standard were considered high-risk, those in the bottom 75% low-risk.  \nWe obtained cancer outcomes, including American Joint Committee on Cancer (AJCC) prognostic pathologic stage, from the San Francisco Mammography Registry and an institutional cancer registry. We examined the associations of BCSC risk scores with advanced (≥ AJCC prognostic stage II) and non-advanced (AJCC prognostic stage I) IBC using Fisher’s exact test and logistic regression.  \nResults Of 11,915 participants, 4,005 (34%) were high-risk. There were 254 incident IBC cases, of which 40 (16%) were advanced and 214 (84%) were non-advanced. The median 5-year BCSC risk score for women with and without IBC was 1.83% and 1.45%, respectively (p \u003C 0.001) . High BCSC risk among women diagnosed with breast cancer was associated with non-advanced cancer (OR = 2.25, 95% CI = 1.71–2.95, p \u003C 0.0001), but not with advanced cancer (OR = 1.20, 95% CI = 0.63–2.29, p = 0.57) compared to women not diagnosed with breast cancer.  \nConclusion High BCSC risk scores were associated with high rates of non-advanced IBC. As non-advanced cancers are more likely to be hormone receptor-positive, BCSC may optimally identify candidates for endocrine risk reduction.  \nKeywords Risk asssessment · Breast screening · Prevention · Cohort study  \n\n| Abstract presented at the 2022 SABCS conference. |\n| --- |\n| Katherine Leggat-Barr and Tomiyuri Lewis co-first authors. |\n\n* Laura van’t Veer [Laura.vantveer@ucsf.edu](Laura.vantveer@ucsf.edu)  \n1 University of California, San Francisco, San Francisco, CA 94115, USA  \n2 Stanford Medical Center, Stanford, CA 94305, USA  \n3 University of California, Davis, Sacramento, CA 95817, USA  \n4 Karolinska Institute, Stockholm, Sweden  \n5 Weill Cornell Medicine, New York, NY 10065, USA  \n6 Department of Laboratory Medicine, University California San Francisco, 2340 Sutter St.,, San Francisco, CA 94115, USA  \nIntroduction  \nApproximately 240,000 women are diagnosed with breast cancer each year in the United States and 42,000 die of the disease [1]. Current guidelines, including the United States Preventive Services Task Force (USPSTF) [2], the American College of Radiology (ACR) [3], and the American Cancer Society (ACS) [4], offer conflicting screening recommendations, with differing definitions of high-risk and the corresponding screening strategies. Most women receive annual mammography recommendations [5–7], despite differences in level of risk, breast cancer biology, and prognosis.  \nAssessment of individual risk for breast cancer has advanced significantly with the development of breast cancer  \nprediction risk models [8–10] . Each model evaluates a different combination of risk","cbCainYji25IpeKU","https://ap.wps.com/l/cbCainYji25IpeKU","pdf",659321,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer burden and screening recommendations\n## Breast cancer risk prediction models\n## Rationale for aggressiveness-focused prediction","[{\"question\":\"What is the purpose of this study?\",\"answer\":\"To determine whether the BCSC v2 breast cancer risk score is associated with advanced and non-advanced invasive breast cancer.\"},{\"question\":\"How were participants categorized by risk level?\",\"answer\":\"Participants were classified as high-risk if they were in the top 25% and low-risk if they were in the bottom 75% based on age-specific BCSC risk standard.\"},{\"question\":\"What did the results show about advanced versus non-advanced cancer?\",\"answer\":\"High BCSC risk among women diagnosed with breast cancer was associated with non-advanced invasive cancer, but it was not significantly associated with advanced invasive cancer.\"}]","Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network | PDF",1790091817,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e11d23e8f20f71ed0a4ba7ce7b1135fa.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c0ac4c6abbe0faaabb7c40ea1e2941a.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80999fb9d7118fd57cbc766b83620e48.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d6880945486dbe6f324ec1f00807581.webp",980,1301]